Overview

Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)

Status:
Not yet recruiting

Trial end date:
2024-08-31

Target enrollment:

Participant gender:

Summary

This randomized control trial will compare buprenorphine and morphine, two currently used medications for the treatment of neonatal opioid withdrawal syndrome (NOWS), in newborns to determine which medication will reduce the number of days of pharmacological treatment.

Phase:

Phase 3

Details

Lead Sponsor:

Women and Infants Hospital of Rhode Island

Collaborator:

National Institute of General Medical Sciences (NIGMS)

Treatments:

Buprenorphine
Morphine